Maxim Group Initiates Coverage On Rockwell Medical With Buy Rating, Announces Price Target of $5
Maxim Group Initiates Coverage On Rockwell Medical With Buy Rating, Announces Price Target of $5
Maxim集團以買入評級開始對羅克韋爾醫療進行保險,宣佈目標股價爲5美元
Maxim Group analyst Anthony Vendetti initiates coverage on Rockwell Medical (NASDAQ:RMTI) with a Buy rating and announces Price Target of $5.
Maxim集團分析師安東尼·文德蒂以買入評級開始對羅克韋爾醫療(納斯達克股票代碼:RMTI)進行保險,並宣佈目標股價爲5美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。